F40.0 F40.1 F40.2 F41.0
Conditions
Interventions
Group 1: Active Comparator: Manualized exposure-based cognitive behavioral therapy with 15 double-sessions (incl. psychoeducation, exposure, self-management, booster)
Group 2: Experimental group: Manu
Sponsors
Georg-August-Universität Göttingen
Eligibility
Sex/Gender
All
Age
18 Years to 69 Years
Inclusion criteria
Inclusion criteria: Primary diagnosis of panic disorder, agoraphobia, social anxiety disorder, or specific phobia according to DSM-5. At least mild anxiety symptom severity (PROMIS-Anxiety = 20). Outpatient status (i.e., outpatient psychotherapy with weekly sessions for 12 weeks and booster sessions possible). Sufficient German language skills. Informed consent.
Exclusion criteria
Exclusion criteria: Acute suicidality. Current or history of bipolar disorder, psychotic disorder, or borderline personality disorder. Current alcohol, medication, or drug dependence (except nicotine and caffeine; abstinence should be > 6 months). Severe medical conditions that prevent regular participation in therapy or bias research question (e.g., brain damage). Any other general contraindications for exposure or psychotherapy (see Pittig & Pittig, 2024). Any other reason endangering adherence to treatment protocol (e.g., planned inpatient treatment, planned absence or relocation, etc.). Concomitant psychotherapy (inpatient or outpatient). Concomitant psychopharmacological treatment is permitted, provided there has been no change in medication type or dosage during the 3 months prior to study entry.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Exposure-related learning rate based on als exposure exercises from the first three exposure sessions, assessed via patient report of threat expectancy, threat occurence, and adjusted threat expectancy (see Pittig et al., 2023) | — |
Secondary
| Measure | Time frame |
|---|---|
| Threat expectancy change from the exposure sessions via patient report assessed via patient report of threat expectancy and adjusted threat expectancy (see Pittig et al., 2023) | — |
Countries
Germany
Contacts
Public ContactAndre Pittig
Universität Göttingen
Outcome results
None listed